Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
8.57M
-
Shares change
-
+2.15M
-
Total reported value, excl. options
-
$303M
-
Value change
-
+$73.4M
-
Number of buys
-
72
-
Number of sells
-
-29
-
Price
-
$36.26
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q4 2017
121 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q4 2017.
Medpace Holdings, Inc. - Common Stock (MEDP) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.57M shares
of 30.9M outstanding shares and own 27.76% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (1.19M shares), BlackRock Inc. (1.12M shares), BERNZOTT CAPITAL ADVISORS (699K shares), ACADIAN ASSET MANAGEMENT LLC (634K shares), AMERIPRISE FINANCIAL INC (343K shares), Granite Investment Partners, LLC (268K shares), CARDINAL CAPITAL MANAGEMENT LLC /CT (237K shares), Numeric Investors LLC (222K shares), Marshall Wace North America L.P. (209K shares), and TWO SIGMA INVESTMENTS, LP (202K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.